Pharma company Invivyd, Inc. just announced it is working with the US Food and Drug Administration (FDA) on a pathway to ...

The story of the discovery of these molecules 50 years ago shows how the free exchange of ideas can lead to life-changing treatments.

Monoclonal antibodies are similar to the antibodies we produce naturally, but with one distinction: they are made in a lab. This means scientists can design them to bind to a specific target in ...

The global monoclonal antibody therapeutics market is set to witness a growth rate of ~12% in the next 5 years. Rising ...

Monoclonal antibodies (mAbs) make up one of the most important classes of advanced biotherapies. To find out about the current challenges and advances in the production of mAbs, GEN talked with ...

In addition, Sino Biological offers pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.

A “can-do” attitude toward monoclonal antibody (mAb) production developed over the last 30 years has set the groundwork for rapid progress in advanced therapies.

Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal ...

A monoclonal antibody (mAb) works by the same principle. mAbs are produced in a lab and target a specific factor in your body, such as a protein on the surface of a cell.

SAN DIEGO — An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, according to a poster presented here. This molecular ...

Monoclonal antibody treatments are typically expensive. But Seder believes costs can be lowered to a reasonable range if the clinical trial results indicate that the treatment can save lives.